Literature DB >> 7749038

Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis.

M Matsuda1, N Tsukada, C S Koh, T Iwahashi, K Shimada, N Yanagisawa.   

Abstract

We investigated the expression of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) by cells in the central nervous system (CNS) of Lewis rats during acute experimental allergic encephalomyelitis (EAE). A few endothelial cells in the CNS of normal rats expressed ICAM-1, whereas during the active phase of EAE, ICAM-1 was present on many endothelial cells. This alteration was detectable the day before clinical symptoms. Since histopathological studies showed few detectable mononuclear cells or inflammatory foci in any section of the preclinical rats, the expression of ICMA-1 was considered to be important at least in the early stage of inflammation. LFA-1 was seen on perivascular infiltrating cells. An increase in either ICAM-1- or LFA-1-positive cells was initially seen in the lumbosacral portion of the spinal cord, which then extended to the thoracic portion. The number of either ICAM-1- or LFA-1-positive cells peaked on the day of clinical onset in the lumbosacral portion. In contrast, in the thoracic portion, a peak in the number of either ICAM-1- or LFA-1-positive cells was observed on the day after clinical onset. This ascending extension of either ICAM-1- or LFA-1-positive cells was correlated with the progression of neurologic signs. It is suggested that increased expression of ICAM-1 and LFA-1 in the CNS of rat EAE may promote the extravasation of lymphocytes across the blood-brain barrier and be related to progression of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7749038     DOI: 10.3109/08916939409008004

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier.

Authors:  Sandip Ashok Sonar; Shagufta Shaikh; Nupura Joshi; Ashwini N Atre; Girdhari Lal
Journal:  Immunol Cell Biol       Date:  2017-07-06       Impact factor: 5.126

3.  Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.

Authors:  Lawrence G Miller; Jennifer A Young; Swapan K Ray; Guanghu Wang; Sharad Purohit; Naren L Banik; Somsankar Dasgupta
Journal:  Neurochem Res       Date:  2017-05-05       Impact factor: 3.996

4.  Increased LFA-1 expression in intestines of rats with GVHD after small bowel transplantation.

Authors:  L S Poritz; G J Olt; F M Ruggiero; P Colony; A F Tilberg; W A Koltun
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes.

Authors:  Florent Lemaître; Negar Farzam-Kia; Ana Carmena Moratalla; Yves Carpentier Solorio; Marie-Laure Clenet; Olivier Tastet; Aurélie Cleret-Buhot; Jean Victor Guimond; Elie Haddad; Pierre Duquette; J Marc Girard; Alexandre Prat; Catherine Larochelle; Nathalie Arbour
Journal:  J Neuroinflammation       Date:  2022-09-01       Impact factor: 9.587

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.